Form D · Biotechnology
BrightHorse Equine Performance, Inc.
San Marcos, CA · CIK 0001997276
Offering snapshot reported Oct 24, 2023 · SEC filing
- Reported sold
- $200K Offering amount: $2.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Sep 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2023 | Initial | $200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495520
Source: Form D, filed Oct 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gary Cantu | Director, Executive |
| Reghu Rajan Kunnath | Executive |
| Ted P. Vlahos | Executive |
| Jose Wong | Director |
| Charles Philip Zahl | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
420 North Twin Oaks Valley Road #2277
San Marcos, CA, 92069
San Marcos, CA, 92069